Advisor Group’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$430K Sell
19,418
-968
-5% -$22.4K ﹤0.01% 1783
2019
Q3
$483K Buy
+20,386
New +$473K ﹤0.01% 1640
2019
Q1
Sell
-24,874
Closed -$550K 5213
2018
Q4
$550K Buy
24,874
+19,548
+367% +$416K 0.01% 1335
2018
Q3
$107K Buy
+5,326
New +$107K ﹤0.01% 2706
2016
Q3
Sell
-328
Closed -$7K 4473
2016
Q2
$7K Buy
+328
New +$7.21K ﹤0.01% 3628

Other funds holding BTAL

Advisor Group's BTAL Position: Q4 2019 in Review

Advisor Group reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 4.7% in Q4 2019, selling an estimated $22.4K and leaving 19,418 shares worth $430K. The position accounts for ﹤0.01% of the portfolio, ranked #1783.

Advisor Group first reported a position in BTAL in Q2 2016 and has held it in 5 quarters since. The position peaked at $550K in Q4 2018. 27 funds tracked by Wall St. Rank hold BTAL as of Q4 2019.

  • Advisor Group held 19,418 shares of AGF US Market Neutral Anti-Beta Fund worth $430K as of Q4 2019.
  • Advisor Group sold 968 AGF US Market Neutral Anti-Beta Fund shares in Q4 2019, an estimated $22.4K.
  • AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #1783 holding.
  • Advisor Group first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2016 and has held it in 5 quarters since.
  • Advisor Group's AGF US Market Neutral Anti-Beta Fund position peaked at $550K in Q4 2018.
  • 27 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.